Haidopoulos Dimitrios, Diakomanolis Emmanuel, Rodolakis Alexandros, Voulgaris Zannis, Vlachos George, Michalas Stylianos
1st Department of Obstetrics and Gynecology, University of Athens, Alexandra Hospital, Greece.
Aust N Z J Obstet Gynaecol. 2005 Feb;45(1):60-3. doi: 10.1111/j.1479-828X.2005.00337.x.
To evaluate the coexistence of verrucous and squamous carcinoma of the vulva and to assess the clinical course, survival and rate of recurrent disease of these patients.
The records of 17 patients who were diagnosed with verrucous carcinoma of the vulva over a 12-year period were studied retrospectively. Presence of genuine verrucous carcinoma or coexistence of verrucous and squamous carcinoma of the vulva on vulvar biopsies, results of histopathological assessment of final vulva and inguino-femoral node specimens and histological evaluation of recurrent disease specimens were the main outcome measures.
Five of the 17 patients (29.5%) initially underwent radical vulvectomy and inguino-femoral lymphadenectomy. Histology of the specimens verified the coexistence of verrucous and squamous carcinomas in four of the five cases. Twelve women (70.5%) underwent simple vulvectomy for genuine verrucous carcinoma; in the final histology, 10 of these women (58.8%) were confirmed as having genuine verrucous carcinomas while two (11.7%) were found to have both verrucous and squamous carcinomas and were further managed by lymphadenectomy. None of our patients died of the disease. Three women (17.5%) presented with local relapse of the tumour, and were managed by wide local excision of the tumour.
In the present study, 35% of patients with verrucous carcinomas of the vulva had coexistent squamous carcinoma. Separation of the cases of genuine verrucous carcinoma from coexistent verrucous and squamous tumours is based on the establishment of correct diagnosis by a large and deep vulvar biopsy as well as the meticulous assessment of the specimen by the pathologist. This will result in the decrease of the rate of over- and under-treatment of these patients.
评估外阴疣状癌与鳞状细胞癌的共存情况,并评估这些患者的临床病程、生存率及疾病复发率。
回顾性研究12年间确诊为外阴疣状癌的17例患者的病历。主要观察指标包括外阴活检中真性疣状癌的存在情况或外阴疣状癌与鳞状细胞癌的共存情况、最终外阴及腹股沟股淋巴结标本的组织病理学评估结果以及复发病灶标本的组织学评估结果。
17例患者中有5例(29.5%)最初接受了根治性外阴切除术及腹股沟股淋巴结清扫术。标本组织学检查证实,5例中有4例疣状癌与鳞状细胞癌共存。12例女性(70.5%)因真性疣状癌接受了单纯外阴切除术;最终组织学检查显示,其中10例女性(58.8%)确诊为真性疣状癌,2例(11.7%)同时患有疣状癌和鳞状细胞癌,随后接受了淋巴结清扫术。所有患者均未死于该疾病。3例女性(17.5%)出现肿瘤局部复发,接受了肿瘤广泛局部切除术。
在本研究中,35%的外阴疣状癌患者同时存在鳞状细胞癌。通过进行大面积深部外阴活检并由病理学家对标本进行细致评估来建立正确诊断,从而将真性疣状癌病例与疣状癌和鳞状细胞癌共存病例区分开来。这将降低这些患者过度治疗和治疗不足的发生率。